TY - JOUR
T1 - Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas
AU - Rodriguez, Ana M.
AU - Do, Thuy Quynh N.
AU - Jibaja-Weiss, Maria L.
AU - Chen, Lu
AU - Schmeler, Kathleen M.
AU - Montealegre, Jane R.
AU - Kuo, Yong Fang
N1 - Publisher Copyright:
© 2022 American Public Health Association Inc.. All rights reserved.
PY - 2022/9
Y1 - 2022/9
N2 - This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr–San Juan–Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers.
AB - This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr–San Juan–Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers.
UR - http://www.scopus.com/inward/record.url?scp=85136908929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136908929&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2022.306970
DO - 10.2105/AJPH.2022.306970
M3 - Article
C2 - 35862887
AN - SCOPUS:85136908929
SN - 0090-0036
VL - 112
SP - 1269
EP - 1272
JO - American journal of public health
JF - American journal of public health
IS - 9
ER -